Cheche Group Inc.
US ˙ NasdaqCM ˙ KYG207071088

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for N Anthony Coles. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at N Anthony Coles har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:REGN / Regeneron Pharmaceuticals, Inc. Director 1.559
US:CERE / Cerevel Therapeutics Holdings, Inc. Director 0
US:YMTX / Yumanity Therapeutics Inc Executive Chair, Director 78.650
US:MCK / McKesson Corporation Director 0
US:CRSP / CRISPR Therapeutics AG Director 15.000
US:ONXX / Onyx Pharmaceuticals Inc Chairman & CEO, Director 0
US:CCG / Cheche Group Inc. Director 3.999
US:LH / Labcorp Holdings Inc. Director 2.584
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af N Anthony Coles. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb CCG / Cheche Group Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CCG / Cheche Group Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CCG / Cheche Group Inc. Insider Trades
Insidersalg CCG / Cheche Group Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CCG / Cheche Group Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CCG / Cheche Group Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af N Anthony Coles som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-01-06 2025-01-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 166 1.559 11,92
2024-08-05 2024-08-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
D - Sale to Issuer -10.290 0 -100,00
2024-08-05 2024-08-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
D - Sale to Issuer -15.638 10.290 -60,31
2024-07-03 2024-07-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -25.000 25.928 -49,09 41,18 -1.029.535 1.067.751
2024-07-03 2024-07-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 25.000 50.928 96,42 3,50 87.500 178.248
2024-06-07 2024-06-05 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
A - Award 10.290 25.928 65,80
2024-06-05 2024-06-03 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50.000 15.638 -76,18 40,61 -2.030.520 635.065
2024-06-05 2024-06-03 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50.000 65.638 319,73 3,50 175.000 229.733
2024-05-14 2024-05-10 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50.000 15.638 -76,18 42,10 -2.105.125 658.399
2024-05-14 2024-05-10 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50.000 65.638 319,73 3,50 175.000 229.733
2024-04-03 2024-04-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50.000 15.638 -76,18 42,33 -2.116.640 662.000
2024-04-03 2024-04-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50.000 65.638 319,73 3,50 175.000 229.733
2024-03-06 2024-03-04 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50.000 15.638 -76,18 41,01 -2.050.550 641.330
2024-03-06 2024-03-04 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50.000 65.638 319,73 3,50 175.000 229.733
2024-03-04 2024-02-29 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50.000 15.638 -76,18 41,16 -2.057.890 643.626
2024-03-04 2024-02-29 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50.000 65.638 319,73 3,50 175.000 229.733
2024-02-08 2024-02-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale -2.506 15.638 -13,81 41,54 -104.110 649.667
2024-02-08 2024-02-06 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise 15.440 18.144 571,01
2024-01-04 2024-01-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 135 1.393 10,73
2024-01-04 2024-01-02 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50.000 2.704 -94,87 42,24 -2.111.815 114.207
2024-01-04 2024-01-02 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50.000 52.704 1.849,11 3,50 175.000 184.464
2023-11-16 2023-11-14 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -22.824 2.704 -89,41 25,13 -573.455 67.938
2023-11-16 2023-11-14 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 22.824 25.528 844,08 3,50 79.884 89.348
2023-11-09 2023-11-08 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -100 2.704 -3,57 25,16 -2.516 68.033
2023-11-09 2023-11-08 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 100 2.804 3,70 3,50 350 9.814
2023-11-09 2023-11-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -27.076 2.704 -90,92 25,02 -677.555 67.665
2023-11-09 2023-11-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 27.076 29.780 1.001,33 3,50 94.766 104.230
2023-11-06 2023-11-03 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -61.401 2.704 -95,78 25,43 -1.561.458 68.764
2023-11-06 2023-11-03 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 61.401 64.105 2.270,75 3,50 214.904 224.368
2023-11-06 2023-11-02 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -38.599 2.704 -93,45 25,19 -972.239 68.109
2023-11-06 2023-11-02 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 38.599 41.303 1.427,48 3,50 135.096 144.560
2023-09-08 2023-09-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50.000 2.704 -94,87 24,07 -1.203.415 65.081
2023-09-08 2023-09-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50.000 52.704 1.849,11 3,50 175.000 184.464
2023-07-13 2023-07-11 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50.000 2.704 -94,87 30,03 -1.501.340 81.192
2023-07-13 2023-07-11 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50.000 52.704 1.849,11 3,50 175.000 184.464
2023-06-05 2023-06-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50.000 2.704 -94,87 32,60 -1.630.070 88.154
2023-06-05 2023-06-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50.000 52.704 1.849,11 3,50 175.000 184.464
2023-05-08 2023-05-04 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -300 2.704 -9,99 32,93 -9.879 89.043
2023-05-08 2023-05-04 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -12.132 3.004 -80,15 31,76 -385.287 95.401
2023-05-08 2023-05-04 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -37.568 15.136 -71,28 31,36 -1.178.268 474.719
2023-05-08 2023-05-04 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50.000 52.704 1.849,11 3,50 175.000 184.464
2023-04-13 2023-04-11 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50.000 2.704 -94,87 25,06 -1.253.130 67.769
2023-04-13 2023-04-11 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50.000 52.704 1.849,11 3,50 175.000 184.464
2023-03-06 2023-03-03 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -3.000 2.704 -52,59 27,19 -81.570 73.522
2023-03-06 2023-03-03 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 3.000 5.704 110,95 3,50 10.500 19.964
2023-03-06 2023-03-02 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -47.000 2.704 -94,56 27,11 -1.274.377 73.317
2023-03-06 2023-03-02 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 47.000 49.704 1.738,17 3,50 164.500 173.964
2023-02-08 2023-02-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -7.942 2.704 -74,60 33,57 -266.649 90.785
2023-02-08 2023-02-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -42.058 10.646 -79,80 33,04 -1.389.752 351.783
2023-02-08 2023-02-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50.000 52.704 1.849,11 3,50 175.000 184.464
2023-01-06 2023-01-05 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -500 2.704 -15,61 30,73 -15.366 83.099
2023-01-06 2023-01-05 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -49.500 3.204 -93,92 29,93 -1.481.505 95.894
2023-01-06 2023-01-05 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50.000 52.704 1.849,11 3,50 175.000 184.464
2023-01-05 2023-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 165 1.258 15,10
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -311 1.093 -22,15 716,08 -222.701 782.675
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.266 1.404 -61,74 715,48 -1.621.278 1.004.534
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.022 3.670 -21,78 714,61 -730.331 2.622.619
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.198 4.692 -20,34 713,66 -854.965 3.348.493
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -100 5.890 -1,67 711,95 -71.195 4.193.386
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -679 5.990 -10,18 710,63 -482.518 4.256.674
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1 6.669 -0,01 709,92 -710 4.734.456
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -181 6.670 -2,64 707,87 -128.124 4.721.493
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3.613 6.851 111,58 482,68 1.743.923 3.306.841
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2.145 3.238 196,25 374,12 802.487 1.211.401
2022-12-13 2022-12-09 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -5.145 2.704 -65,55 27,09 -139.395 73.260
2022-12-13 2022-12-09 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -44.855 7.849 -85,11 26,62 -1.193.906 208.917
2022-12-13 2022-12-09 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50.000 52.704 1.849,11 3,50 175.000 184.464
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -602 1.093 -35,52 584,57 -351.911 638.935
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.045 1.695 -38,14 583,16 -609.402 988.456
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.220 2.740 -30,81 582,56 -710.723 1.596.214
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -822 3.960 -17,19 581,44 -477.944 2.302.502
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -688 4.782 -12,58 580,44 -399.343 2.775.664
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -550 5.470 -9,14 579,85 -318.918 3.171.780
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -273 6.020 -4,34 578,25 -157.862 3.481.065
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -500 6.293 -7,36 577,07 -288.535 3.631.502
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3.784 6.793 125,76 371,40 1.405.378 2.522.920
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -300 3.009 -9,07 576,73 -173.019 1.735.381
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2.216 3.309 202,74 374,12 829.050 1.237.963
2022-02-11 2022-02-09 4 CERE Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
A - Award 425.772 425.772
2022-01-05 2022-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 2.707 2.707
2022-01-05 2022-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 191 1.093 21,18
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -6.909 0 -100,00
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.039 0 -100,00
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.174 902 -56,55 664,32 -779.912 599.217
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -905 2.076 -30,36 663,73 -600.676 1.377.903
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3 2.981 -0,10 662,55 -1.988 1.975.062
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.344 2.984 -52,84 661,56 -2.212.257 1.974.095
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -448 6.328 -6,61 660,78 -296.029 4.181.416
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -300 6.776 -4,24 659,00 -197.700 4.465.384
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -935 7.076 -11,67 658,65 -615.838 4.660.607
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -835 8.011 -9,44 657,53 -549.038 5.267.473
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.400 8.846 -13,66 656,48 -919.072 5.807.222
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -403 10.246 -3,78 655,14 -264.021 6.712.564
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -800 10.649 -6,99 653,31 -522.648 6.957.098
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.101 11.449 -8,77 652,95 -718.898 7.475.625
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -300 12.550 -2,33 651,36 -195.408 8.174.568
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5.039 12.850 64,51 345,47 1.740.823 4.439.290
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6.909 7.811 765,96 380,95 2.631.984 2.975.600
2021-08-19 2021-08-18 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.100 5.039 -50,30
2021-08-19 2021-08-18 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5.100 902 -84,97 650,00 -3.315.000 586.300
2021-08-19 2021-08-18 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5.100 6.002 565,41 345,47 1.761.897 2.073.511
2021-08-19 2021-08-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -900 10.139 -8,15
2021-08-19 2021-08-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -900 902 -49,94 650,00 -585.000 586.300
2021-08-19 2021-08-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 900 1.802 99,78 345,47 310.923 622.537
2021-08-16 2021-08-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -2.000 11.039 -15,34
2021-08-16 2021-08-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.000 902 -68,92 625,00 -1.250.000 563.750
2021-08-16 2021-08-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2.000 2.902 221,73 345,47 690.940 1.002.554
2021-04-02 2021-04-01 4 YMTX YUMANITY THERAPEUTICS, INC.
Stock Option (Right to Buy)
A - Award 78.650 78.650
2021-02-05 2021-02-03 4 CERE Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
A - Award 732.714 732.714
2021-02-03 2021-02-01 4 YMTX YUMANITY THERAPEUTICS, INC.
Common Stock
A - Award 1.118 691.008 0,16
2021-01-05 2021-01-04 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 3.613 3.613
2021-01-05 2021-01-04 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 248 902 37,92
2020-12-28 2020-12-22 4 YMTX YUMANITY THERAPEUTICS, INC.
Warrant (Right to Buy)
A - Award 6.038 6.038
2020-12-28 2020-12-22 4 YMTX YUMANITY THERAPEUTICS, INC.
Stock Option (Right to Buy)
A - Award 12.082 12.082
2020-12-28 2020-12-22 4 YMTX YUMANITY THERAPEUTICS, INC.
Stock Option (Right to Buy)
A - Award 72.496 72.496
2020-12-28 2020-12-22 4 YMTX YUMANITY THERAPEUTICS, INC.
Common Stock
A - Award 52.669 52.669
2020-12-28 2020-12-22 4 YMTX YUMANITY THERAPEUTICS, INC.
Common Stock
A - Award 689.890 689.890
2020-11-13 2020-11-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -11 13.039 -0,08
2020-11-13 2020-11-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11 654 1,71 345,47 3.800 225.937
2020-10-30 2020-10-28 4 CERE Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
A - Award 196.335 196.335
2020-08-19 2020-08-17 4 MCK MCKESSON CORP
Common Stock
S - Sale -2.453 0 -100,00 156,77 -384.559
2020-07-31 2020-07-29 4 MCK MCKESSON CORP
Common Stock
A - Award 1.157 2.453 89,27
2020-01-06 2020-01-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 4.361 4.361
2020-01-06 2020-01-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 320 643 99,07
2019-08-01 2019-07-31 4 MCK MCKESSON CORP
Common Stock
A - Award 1.296 1.296
2019-01-04 2019-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 3.784 3.784
2019-01-04 2019-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
A - Award 323 323
2018-09-04 2018-08-31 4 MCK MCKESSON CORP
Common Stock
S - Sale X -1.350 0 -100,00 128,69 -173.732
2018-07-26 2018-07-25 4 MCK MCKESSON CORP
Common Stock
A - Award 1.350 1.350
2018-01-04 2018-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 6.909 6.909
2017-07-27 2017-07-26 4 MCK MCKESSON CORP
Restricted Stock Units (RSUs)
A - Award 1.083 1.083
2017-06-02 2017-05-31 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
A - Award 15.000 15.000
2017-01-31 2017-01-27 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 13.050 13.050
2016-10-26 2016-10-24 4 CRSP CRISPR Therapeutics AG
Common Stock
A - Award 35.000 70.000 100,00 14,00 490.000 980.000
2016-10-26 2016-10-24 4 CRSP CRISPR Therapeutics AG
Common Stock
A - Award 35.000 70.000 100,00 14,00 490.000 980.000
2016-10-20 2016-10-18 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
A - Award 15.000 15.000
2016-07-28 2016-07-27 4 MCK MCKESSON CORP
Restricted Stock Units (RSUs)
A - Award 915 915
2015-07-31 2015-07-29 4 MCK MCKESSON CORP
Restricted Stock Units
A - Award 794 794
2014-07-31 2014-07-30 4 MCK MCKESSON CORP
Restricted Stock Units
A - Award 785 785
2014-05-16 2014-05-15 4 MCK MCKESSON CORP
Restricted Stock Units
A - Award 212 212
2014-05-01 3 MCK MCKESSON CORP
Common Stock
0
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -75.300 0 -100,00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -139.947 0 -100,00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -2.653 0 -100,00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -45.283 0 -100,00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -2.842 0 -100,00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -143.698 0 -100,00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -3.302 0 -100,00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -5.247 0 -100,00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -105.566 0 -100,00 125,00 -13.195.750
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
U - Other -25.632 105.566 -19,54 125,00 -3.204.000 13.195.750
2013-06-07 2013-06-05 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -6.562 48.125 -12,00
2013-06-07 2013-06-05 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -6.562 131.198 -4,76 90,00 -590.580 11.807.820
2013-06-07 2013-06-05 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 6.562 137.760 5,00 35,18 230.851 4.846.397
2013-05-31 2013-04-22 4 CCG Campus Crest Communities, Inc.
Common Stock
D - Sale to Issuer -16.335 3.999 -80,33
2013-04-03 2013-04-03 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -3.502 5.247 -40,03
2013-04-03 2013-04-03 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -13.776 0 -100,00
2013-04-03 2013-04-03 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 3.502 131.198 2,74 28,55 99.982 3.745.703
2013-04-03 2013-04-03 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 13.776 127.696 12,09 29,03 399.917 3.707.015
2013-04-03 2013-04-03 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -1.300 113.920 -1,13 90,81 -118.053 10.345.075
2013-04-03 2013-04-03 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -8.405 115.220 -6,80 89,30 -750.566 10.289.146
2013-04-03 2013-04-01 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -7.859 123.625 -5,98 86,14 -676.974 10.649.058
2013-04-03 2013-04-01 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -3.770 131.484 -2,79 86,14 -324.748 11.326.032
2013-04-01 2013-03-28 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 75.300 75.300
2013-04-01 2013-03-28 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -10.938 54.687 -16,67
2013-04-01 2013-03-28 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
A - Award 26.800 135.254 24,71
2013-04-01 2013-03-28 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -10.938 108.454 -9,16 90,00 -984.420 9.760.860
2013-04-01 2013-03-28 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 10.938 119.392 10,09 35,18 384.799 4.200.211
2013-02-19 2013-02-15 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
G - Gift -216 2.584 -7,71
2013-01-31 2013-01-31 4 CCG Campus Crest Communities, Inc.
Common Stock
A - Award 7.000 20.334 52,50
2012-10-17 2012-10-16 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -39.375 65.625 -37,50
2012-10-17 2012-10-16 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -86.224 13.776 -86,22
2012-10-17 2012-10-16 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -125.599 108.343 -53,69
2012-10-17 2012-10-16 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 39.375 233.942 20,24 35,18 1.385.212 8.230.080
2012-10-17 2012-10-16 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 86.224 194.567 79,58 29,03 2.503.083 5.648.280
2012-08-09 2012-08-08 4 ONXX ONYX PHARMACEUTICALS INC
StockOption (Right to Buy)
M - Exercise -250.000 100.000 -71,43
2012-08-09 2012-08-08 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale -270.690 108.343 -71,42 72,18 -19.538.404 7.820.198
2012-08-09 2012-08-08 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 250.000 379.033 193,75 29,03 7.257.500 11.003.328
2012-08-03 2012-08-01 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -8.820 154.033 -5,42 74,37 -655.943 11.455.434
2012-07-27 2012-07-25 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -11.883 162.853 -6,80 73,97 -879.007 12.046.530
2012-05-29 2012-05-24 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
A - Award 1.800 2.800 180,00
2012-04-03 2012-04-02 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer X -2.406 174.330 -1,36 36,58 -88.007 6.376.660
2012-04-03 2012-04-02 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer X -3.368 176.736 -1,87 36,58 -123.192 6.464.526
2012-04-03 2012-04-02 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer X -2.406 180.104 -1,32 36,58 -88.004 6.587.646
2012-04-03 2012-03-30 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 142.600 142.600
2012-04-03 2012-03-30 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
A - Award 60.100 182.510 49,10
2012-04-03 2012-03-30 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
A - Award 28.000 122.410 29,66
2012-03-29 2012-03-28 4 CCG Campus Crest Communities, Inc.
Common Stock
A - Award 6.667 13.334 100,00
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)